Medication-Assisted Treatment, often called MAT, is an approach that combines FDA-approved medications with counseling and behavioral therapies to support recovery from substance use disorders. It is designed to address both the physical side of addiction and the psychological patterns that keep substance use going. MAT can reduce withdrawal symptoms and cravings, which helps people stay more stable in early recovery and better able to engage in treatment.

MAT is not positioned as a cure. Instead, it can improve the chances of recovery for people dealing with severe addiction by reducing the intensity of early obstacles that often lead to relapse. When cravings and withdrawal feel overwhelming, it can be hard to focus on therapy, group work, and behavior change. MAT helps take the edge off those symptoms so the rest of treatment can work more effectively.

Another important part of MAT is that it is not meant to substitute one addiction for another. Medications are carefully selected to support stability, reduce relapse risk, and help people build long-term recovery skills.

When MAT is paired with counseling and behavioral therapies, it becomes a more complete treatment strategy that supports both immediate stabilization and lasting change.

MAT at Louisville Addiction Center is described as especially helpful for people facing severe cravings and dangerous withdrawal symptoms tied to highly addictive substances. The program is positioned to help with alcohol, benzodiazepines, and opioids, since dependence in these categories can create intense early-recovery symptoms that make relapse more likely.

For opioid use disorders, cravings and withdrawal can be powerful enough to pull someone back into use quickly. MAT is designed to reduce those cravings and ease withdrawal distress, which supports abstinence and lowers the risk of returning to opioids during a vulnerable period. The program also notes that opioid withdrawal carries a serious risk of overdose if relapse occurs, which is one reason stabilization and structured care matter.

For alcohol use disorders, withdrawal can involve severe medical symptoms, including seizures and delirium tremens. MAT is presented as a way to reduce withdrawal symptoms and support safety during early recovery.

For benzodiazepine dependence, withdrawal can also be dangerous and difficult to tolerate. MAT support is positioned as part of a broader treatment plan that includes counseling, behavioral therapies, and ongoing recovery support, rather than medication alone.

Louisville Addiction Center highlights two injectable medications used in its outpatient MAT approach: Vivitrol and Sublocade. The program emphasizes that not all treatment centers offer the same MAT medications, and it specifically chooses options that work well within an outpatient structure.

A key reason for monthly injections is practicality. Some medications, like methadone for opioid addiction, require daily clinic visits for dosing. That level of daily commitment may not fit everyone’s life, schedule, or responsibilities. By contrast, the program’s two injectable options are taken once per month, which can make treatment more accessible and easier to maintain consistently.

Monthly injections also support routine and accountability. When dosing is consistent, cravings and withdrawal symptoms can be better managed across the month, giving someone a stronger chance to stay engaged in counseling and behavioral therapies. The program stresses the importance of sticking to the monthly injection schedule because missing a dose can increase relapse and overdose risk.

While medication can reduce specific symptoms, it is meant to work alongside therapy, group support, and other levels of care. The injection schedule is one part of a broader plan designed to support stability and long-term recovery.

Vivitrol is described as a medication that treats both alcohol and opioid use disorders. Its active ingredient is naltrexone, which blocks opioid receptors in the brain. When opioid receptors are blocked, the effects of opioid drugs are reduced, and the medication can also diminish cravings and urges to use.

In the context of opioid use disorders, this blocking effect is especially important because it can reduce reinforcement if a person returns to opioid use. The program also points out that Vivitrol’s receptor activity supports craving reduction, which can help people stay more stable while they build recovery skills through counseling and behavioral therapy.

Vivitrol is also presented as helpful for alcohol use disorders. Even though alcohol is not an opioid, the program notes that opioid receptors play a role in the euphoric effects someone experiences when drinking. Because naltrexone interacts with those receptors, medications containing naltrexone can support alcohol recovery as well.

Vivitrol is positioned as part of a comprehensive plan, not a standalone solution. When cravings and urges are reduced, many people are better able to focus on therapy, participate more fully, and stay engaged in a recovery routine that supports long-term change.

Sublocade is described as a monthly injectable medication used only for opioid use disorders. Its active medication is buprenorphine, which works differently than naltrexone. Rather than blocking opioid receptors, buprenorphine is a partial opioid agonist, meaning it activates opioid receptors but to a lesser extent than opioid drugs.

This partial activation is presented as a key benefit. Sublocade is described as not producing a high like heroin or fentanyl, while still activating receptors enough to reduce intense cravings. By lowering cravings and minimizing withdrawal severity, Sublocade can help someone stay stable during early recovery when urges to use can be strongest.

The program contrasts this with naltrexone-based medication. Vivitrol blocks opioid receptors, while buprenorphine partially activates them. Even though the mechanisms differ, both approaches are framed around the same recovery goals: reducing cravings, easing withdrawal symptoms, and improving a person’s ability to participate in treatment.

Sublocade is not presented as a replacement for therapy. Instead, it supports stabilization so counseling, behavioral therapies, and ongoing recovery programming can be more effective. In other words, medication helps create a foundation, and the rest of treatment builds the structure needed for long-term sobriety.

MAT is presented as a comprehensive approach for alcohol use disorder that combines medication with counseling and behavioral therapies. The goal is to support recovery by addressing both physical withdrawal symptoms and the ongoing psychological patterns that can drive continued drinking.

One of the key reasons MAT matters for alcohol recovery is the potential severity of withdrawal. The program notes that severe alcohol withdrawal can involve dangerous medical symptoms, including seizures and delirium tremens. Delirium tremens is described as potentially involving mental confusion that can lead someone to take risks or put themselves in harm’s way. Because of these risks, medication support during withdrawal can be positioned as a critical safety measure for people with severe alcohol dependence.

The program also lists benefits of proper MAT for alcohol use disorder, including reducing cravings for alcohol, helping manage withdrawal symptoms, improving treatment retention, supporting long-term recovery, reducing relapse risk, and offering a holistic approach to treatment.

MAT is framed as a support system that helps people stay engaged. When withdrawal symptoms and cravings are reduced, it becomes easier to participate in therapy, follow a treatment plan, and build relapse prevention skills that carry forward after early recovery.

MAT is described as more than medication alone. The program emphasizes that MAT integrates medications with counseling, behavioral therapies, and support to create a comprehensive recovery approach. Medication helps with specific symptoms like cravings and withdrawal, but addiction recovery typically requires deeper work to address behaviors, coping patterns, and underlying drivers of substance use.

A major advantage of MAT is that it can help people engage more fully in treatment. When someone is distracted by intense cravings or feels physically distressed from withdrawal, participation can drop and motivation can feel unstable. MAT medications can reduce that burden, helping a person focus on therapy, group work, and behavior change instead of fighting symptoms all day.

The program highlights multiple ways MAT supports recovery, including alleviating withdrawal symptoms, diminishing cravings, blocking the effects of drugs, stabilizing brain function, supporting abstinence, enhancing treatment retention, reducing the risk of overdose and other health-related conditions, and establishing a stable foundation for recovery.

Therapy remains essential because medication does not teach coping skills, rebuild relationships, or address relapse triggers by itself. Counseling and behavioral therapies help people develop tools for stress, emotion regulation, and decision-making. MAT supports stability so therapy can do its job more effectively, creating a stronger pathway to long-term sobriety.

The information presented on Louisville Addiction Center website pages is intended solely for general educational and informational purposes related to addiction treatment, medical detoxification, rehabilitation services, and recovery support. This content is not intended to serve as medical advice, diagnosis, treatment planning, or a substitute for professional medical care. Substance use disorders are complex medical conditions that require individualized evaluation by qualified healthcare professionals.

Detoxification and rehabilitation needs vary widely based on the type of substance used, duration and frequency of use, physical health, mental health history, co-occurring disorders, and other individual factors. Information discussing detox timelines, withdrawal symptoms, medications, or treatment approaches is generalized and may not apply to every individual. Treatment decisions should always be made in consultation with licensed physicians, addiction specialists, or behavioral health providers.

If you or someone you love is experiencing a medical emergency — including but not limited to overdose, seizures, loss of consciousness, breathing difficulties, chest pain, suicidal thoughts, or violent behavior — call 911 immediately or go to the nearest emergency room. Louisville Addiction Center does not provide emergency medical services through this website, and no online content should delay urgent medical intervention.

Attempting to detox from alcohol, opioids, benzodiazepines, or other substances without medical supervision can be dangerous and potentially life-threatening. Withdrawal symptoms can be unpredictable and severe. Any detox-related information provided is for awareness only and should never replace professional medical oversight.

Information regarding insurance coverage, treatment costs, or payment options is provided for general guidance purposes only. Insurance benefits vary by carrier, policy, state regulations, and medical necessity determinations. Coverage information is not guaranteed and may change without notice. Louisville Addiction Center strongly encourages individuals to contact our admissions team directly to verify insurance benefits, eligibility, and coverage prior to making treatment decisions.

While reasonable efforts are made to ensure accuracy, Louisville Addiction Center makes no warranties regarding the completeness or timeliness of website content. Healthcare regulations, clinical standards, and insurance policies evolve regularly. Reliance on any information provided is at your own risk.

This website may include references or links to third-party resources for informational purposes. Such references do not constitute endorsements. Louisville Addiction Center is not responsible for external content, services, or policies.

Use of this website does not establish a provider-patient relationship. Contacting Louisville Addiction Center does not guarantee admission or treatment. Recovery outcomes vary and are never guaranteed.

All content published on Louisville Addiction Center website pages is provided for informational purposes only and should not be interpreted as medical, psychological, or legal advice. This information is not intended to diagnose, treat, cure, or prevent any disease or condition and should not replace consultation with licensed healthcare professionals.

Addiction is a chronic, relapsing medical condition that requires individualized care. Treatment approaches, detox protocols, and rehabilitation services vary depending on numerous factors unique to each individual. No information on this website should be relied upon to make treatment decisions without professional guidance.

If you are experiencing an emergency situation, including overdose, withdrawal complications, suicidal ideation, or immediate risk to yourself or others, call 911 immediately. Louisville Addiction Center does not provide emergency medical services online or via website communication.

Never attempt to discontinue substance use or begin detox without proper medical supervision. Withdrawal can cause serious medical complications. Any information regarding detoxification is general in nature and does not substitute for physician-directed care.

Insurance information presented on this website is intended solely to assist users in understanding potential coverage options. Coverage is subject to verification, medical necessity determinations, and policy limitations. Louisville Addiction Center encourages direct contact with our admissions specialists to confirm benefits and eligibility.

We do not guarantee treatment outcomes, length of stay, insurance approvals, or placement availability. Outcomes depend on numerous clinical and personal factors.

External links are provided for convenience and informational purposes only. Louisville Addiction Center assumes no responsibility for third-party content or practices.

Use of this website does not establish a doctor-patient or therapist-patient relationship. Recovery requires professional support and individualized care.

American Psychological Association. (n.d.). Evidence‑based treatment for opioid use disorder. APA Publications. https://www.apa.org/topics/substance-use-abuse-addiction/evidence-based-treatment-opioids Clean Slate Centers+15Louisville Addiction Center+15Louisville Addiction Center+15American Psychological Association

Best Practices: Medication‑Assisted Treatment. (n.d.). Vital Alabama / MH Alabama PDF. https://vitalalabama.com/wp-content/uploads/2022/10/MAT-Digital-PDF_10-6.pdf VitAL Alabama

Jermyn, J. (2022). Review of medication‑assisted treatment for opioid use disorder. Journal of Osteopathic Medicine, 122(7). https://doi.org/10.1515/jom-2021-0163 Recovery.com+15De Gruyter Brill+15SAGE Journals+15

SAMHSA. (n.d.). Medication‑Assisted Treatment Models of Care for Opioid Use Disorder in Primary Care Settings: Technical Brief. SAMHSA Evidence‑Based Practices Resource Center. https://www.samhsa.gov/resource/ebp/medication-assisted-treatment-models-care-opioid-use-disorder-primary-care-settings SAMHSA+1

The American Journal of Managed Care. (n.d.). An overview of medication‑assisted treatment for opioid and alcohol use disorders. AJMC. https://www.ajmc.com/view/an-overview-of-medication-assisted-treatment-for-opioid-and-alcohol-use-disorders